12
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Postprandial Effects of SMS 201-995 on Gut Hormones and Glucose Tolerance

, , &
Pages 73-83 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

E. Pucci & F. Petraglia. (1997) Treatment of androgen excess in females: Yesterday, today and tomorrow. Gynecological Endocrinology 11:6, pages 411-433.
Read now
C. B. H. W. Lamers. (1988) Hormonal Regulation of Gastric Acid in Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology 23:sup146, pages 5-10.
Read now

Articles from other publishers (27)

Manawa Diwekar-Joshi & Milind Watve. (2020) Driver versus navigator causation in biology: the case of insulin and fasting glucose. PeerJ 8, pages e10396.
Crossref
A. P. van Beek, M. Emous, M. Laville & J. Tack. (2017) Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obesity Reviews 18:1, pages 68-85.
Crossref
Christiane Damgé, Jacky Vonderscher, Peter Marbach & Michel Pinget. (1997) Poly(alkyl cyanoacrylate) Nanocapsules as a Delivery System in the Rat for Octreotide, a Long-acting Somatostatin Analogue. Journal of Pharmacy and Pharmacology 49:10, pages 949-954.
Crossref
Jan Tack, Joris Arts, Philip Caenepeel, Dominiek De Wulf & Raf Bisschops. (2009) Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nature Reviews Gastroenterology & Hepatology 6:10, pages 583-590.
Crossref
Joris Arts, Philip Caenepeel, Raf Bisschops, Dominiek Dewulf, Lieselot Holvoet, Hubert Piessevaux, Stefan Bourgeois, Daniel Sifrim, Jozef Janssens & Jan Tack. (2009) Efficacy of the Long-Acting Repeatable Formulation of the Somatostatin Analogue Octreotide in Postoperative Dumping. Clinical Gastroenterology and Hepatology 7:4, pages 432-437.
Crossref
C R Mackie, S A Jenkins & M N Hartley. (1991) Treatment of severe postvagotomy/postgastrectomy symptoms with the somatostatin analogue octreotide. British Journal of Surgery 78:11, pages 1338-1343.
Crossref
Torben Laursen. (2004) Clinical pharmacological aspects of growth hormone administration. Growth Hormone & IGF Research 14:1, pages 16-44.
Crossref
Lars Neisig Møller, Carsten Enggaard Stidsen, Bolette Hartmann & Jens Juul Holst. (2003) Somatostatin receptors. Biochimica et Biophysica Acta (BBA) - Biomembranes 1616:1, pages 1-84.
Crossref
Maurizio Di Mauro, G Papalia, R Le Moli, B Nativo, F Nicoletti & M Lunetta. (2001) Effect of octreotide on insulin requirement, hepatic glucose production, growth hormone, glucagon and c-peptide levels in type 2 diabetic patients with chronic renal failure or normal renal function. Diabetes Research and Clinical Practice 51:1, pages 45-50.
Crossref
Torben Laursen, Jens Møller, Sanne Fisker, Jens O.L. Jørgensen & Jens S. Christiansen. (1999) Effects of a 7-day continuous infusion of octreotide on circulating levels of growth factors and binding proteins in growth hormone (GH)-treated GH-deficient patients. Growth Hormone & IGF Research 9:6, pages 451-457.
Crossref
M Lunetta, M Di Mauro, R Le Moli & F Nicoletti. (1997) Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients. Diabetes Research and Clinical Practice 38:2, pages 81-89.
Crossref
Pierre Martineau, Jill A. Shwed & Ronald Denis. (1996) Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?. The American Journal of Surgery 172:4, pages 386-395.
Crossref
B. D. MAES, Y. F. GHOOS, B. J. GEYPENS, M. I. HIELE & P. J. RUTGEERTS. (2007) Influence of octreotide on the gastric emptying of solids and liquids in normal healthy subjects. Alimentary Pharmacology & Therapeutics 9:1, pages 11-18.
Crossref
Dara Schuster, Thomas M. O’Dorisio & Kwame Osei. (1994) Defective Beta and Alpha Cell Regulation in Patients With Hyperinsulinemiaand Acanthosis Nigricans. The American Journal of the Medical Sciences 307:5, pages 342-345.
Crossref
J. L. Meijer, L. F. S. J. Crobach, J. B. M. J. Jansen & C. B. H. W. Lamers. (1994) Effect of synthetic prostaglandin E2 analog enprostil on omeprazole-induced hypergastrinemia and hyperpepsinogenemia. Digestive Diseases and Sciences 39:3, pages 609-616.
Crossref
Zhenze Hu, Emmett G.C. Tse, Donald C. Monkhouse, Choon K. Oh & David Fleisher. (1994) The intestinal uptake of “enzymatically-stable” peptide drugs in rats as influenced by D-glucose in situ. Life Sciences 54:25, pages 1977-1985.
Crossref
K.E. Gyr & R. Meier. (1992) Pharmacodynamic effects of Sandostatin® in the gastrointestinal tract. Metabolism 41:9, pages 17-21.
Crossref
Alan G. Harris. (2012) Octreotide in the Treatment of Disorders of the Gastrointestinal System. Drug Investigation 4:S3, pages 1-54.
Crossref
Everett J. Mozell, Eugene A. Woltering & Thomas M. O'Dorisio. (1991) Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy. Disease-a-Month 37:12, pages 749-810.
Crossref
Thomas M. O'Dorisio, Hagop S. Mekhjian, John E. Fassler, M. Sue O'Dorisio, Eugene A. Woltering, Timothy S. Gaginella, Thomas A. Gable & William R. Gower. 1990. Gastrointestinal Endocrinology. Gastrointestinal Endocrinology 407 421 .
Paul N. Maton. (1989) The Use of the Long-Acting Somatostatin Analogue, Octreotide Acetate, in Patients with Islet Cell Tumors. Gastroenterology Clinics of North America 18:4, pages 897-922.
Crossref
G. Williams & S.R. Bloom. (2009) Regulatory peptides, the hypothalamus and diabetes. Diabetic Medicine 6:6, pages 472-485.
Crossref
Walter Londong, Michael Angerer, Klaus Kutz, Ruediger Landgraf & Vera Londong. (1989) Diminishing efficacy of octreotide (SMS 201-995) on gastric functions of healthy subjects during one-week administration. Gastroenterology 96:3, pages 713-722.
Crossref
Walter Londong, Michael Angerer, Klaus Kutz, Ruediger Landgraf & Vera Londong. (1989) Diminishing Efficacy of Octreotide (SMS 201-995) on Gastric Functions of Healthy Subjects During One-Week Administration. Gastroenterology 96:2, pages 713-722.
Crossref
M. J. Dunne, R. Elton, T. Fletcher, P. Hofker & J. Shui. 1989. Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors. Sandostatin® in the Treatment of Gastroenteropancreatic Endocrine Tumors 93 113 .
Jack M. Rosenberg. (1988) Octreotide: A Synthetic Analog of Somatostatin. Drug Intelligence & Clinical Pharmacy 22:10, pages 748-754.
Crossref
R. G. LONG. (2007) Review: long‐acting somatostatin analogues. Alimentary Pharmacology & Therapeutics 1:3, pages 191-200.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.